Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MorphoSys extends license agreement with Shionogi
The research will be run by the company’s AbD Serotec unit for three additional years. As per the deal, Shionogi will continue to have the right to use
The research will be run by the company’s AbD Serotec unit for three additional years. As per the deal, Shionogi will continue to have the right to use
The funds are received by a facility which tests new cancer drugs, a project dealing with lung cancer treatment undertaken by a biopharmaceutical company on a new drug
B-Chillin comprises therapeutic dosages of eight stress-reducing nutrients, including magnesium, chloride, L-theanine, GABA, seawater trace mineral concentrate, lemon balm, holy basil, and chamomile. Amrion founder and chairman of
Apokyn (apomorphine hydrochloride injection) is used to treat acute hypomobility ‘off’ episodes linked to advanced Parkinson’s disease. Following the move, Ipsen will not record Apokyn sales in its
The clonidine Lauriad is used to prevent radiotherapy-induced oral mucositis in patients with head and neck cancer. BioAlliance Pharma COO Judith Greciet said the European designation for clonidine
Felodipine XR Tablets are the generic equivalent to AstraZeneca’s Plendil XR Tablets. The company’s generic business unit – Qualitest Pharmaceuticals will manufacture and distribute the Felodipine XR Tablets.
The AbSolute High Cap is based on modified silica and will capture both monoclonal and polyclonal antibodies from high titer and large volume feedstock. According to the company,
The data was published in the New England Journal of Medicine (NEJM). The Phase 3 STRIVE study evaluated 161 patients 12 years or older who received at least
The Phase II study included comparison of the safety, tolerability and pharmacokinetic profiles of PG-free melphalan intravenous formulation to the standard multiple myeloma treatment. The Captisol-enabled drug is
The injection is indicated to treat cancer and is administered intravenously, hindubusinessline.com reported. The drug in the strengths of 10 mg/ vial and 50 mg/ vial, received approval